Gut microbiota and allergic disease: New findings

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 17, Issue 3, 2014, Pages 261-266

  West, Christina E ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

allergy prevention; gut microbiome; intestinal colonization; oral microbiota; probiotics

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT;

ALLERGIC DISEASE; CESAREAN SECTION; DIETARY FIBER; ENVIRONMENTAL EXPOSURE; FOLLOW UP; HUMAN; INTESTINE FLORA; MICROBIAL COLONIZATION; MICROBIAL DIVERSITY; MOUTH FLORA; NONHUMAN; PREGNANCY; PRIMARY PREVENTION; REVIEW; ECZEMA; FEMALE; HYPERSENSITIVITY; INFANT; INTESTINE; MICROBIOLOGY; MICROFLORA; MOUTH; NEWBORN; PHYSIOLOGY;

CESAREAN SECTION; ECZEMA; FEMALE; HUMANS; HYPERSENSITIVITY; INFANT; INFANT, NEWBORN; INTESTINES; MICROBIOTA; MOUTH; PREBIOTICS; PREGNANCY; PROBIOTICS;

EID: 84898538639     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0000000000000044     Document Type: Review

References (62)

1. Fouhy F, Ross RP, Fitzgerald GF, et al. Composition of the early intestinal microbiota: knowledge, knowledge gaps and the use of high-throughput sequencing to address these gaps. Gut Microbes 2012; 3:203-220.
2. Lozupone CA, Stombaugh JI, Gordon JI, et al. Diversity, stability and resilience of the human gut microbiota. Nature 2012; 489:220-230.
3. Castro-Sanchez P, Martin-Villa JM. Gut immune system and oral tolerance. Br J Nutr 2013; 109 (Suppl 2):S3-S11.
4. Nicholson JK, Holmes E, Kinross J, et al. Host-gut microbiota metabolic interactions. Science 2012; 336:1262-1267.
5. Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464:59-65.
6. Leone V, Chang EB, Devkota S. Diet, microbes, and host genetics: the perfect storm in inflammatory bowel diseases. J Gastroenterol 2013; 48:315-321.
7. Carlisle EM, Morowitz MJ. The intestinal microbiome and necrotizing enterocolitis. Curr Opin Pediatr 2013; 25:382-387.
8. Prescott SL. Early-life environmental determinants of allergic diseases and the wider pandemic of inflammatory noncommunicable diseases. J Allergy Clin Immunol 2013; 131:23-30.
9. Strachan DP. Hay fever, hygiene, and household size. Br Med J 1989; 299:1259-1260.
10. Wold AE. The hygiene hypothesis revised: is the rising frequency of allergy due to changes in the intestinal flora? Allergy 1998; 53 (46 Suppl):20-25.
11. Rautava S, Luoto R, Salminen S, et al. Microbial contact during pregnancy, intestinal colonization and human disease. Nature Rev Gastroenterol Hepatol 2012; 9:565-576.
12. Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature 2012; 486:222-227.
13. Azad MB, Konya T, Maughan H, et al. Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months. CMAJ 2013; 185:385-394.
14. Jakobsson HE, Abrahamsson TR, Jenmalm MC, et al. Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by Caesarean section. Gut 2013. [Epub ahead of print]
15. Penders J, Gerhold K, Stobberingh EE, et al. Establishment of the intestinal microbiota and its role for atopic dermatitis in early childhood. J Allergy Clin Immunol 2013; 132:601-607; e8.
16. Fouhy F, Guinane CM, Hussey S, et al. High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin. Antimicrob Agents Chemother 2012; 56:5811-5820.
17. Rautava S, Collado MC, Salminen S, Isolauri E. Probiotics modulate hostmicrobe interaction in the placenta and fetal gut: a randomized, double-blind, placebo-controlled trial. Neonatology 2012; 102:178-184.
18. Funkhouser LJ, Bordenstein SR. Mom knows best: the universality of maternal microbial transmission. PLoS Biol 2013; 11:e1001631.
19. Gosalbes MJ, Llop S, Valles Y, et al. Meconium microbiota types dominated by lactic acid or enteric bacteria are differentially associated with maternal eczema and respiratory problems in infants. Clin Exp Allergy 2013; 43:198-211.
20. Barouki R, Gluckman P, Grandjean P, et al. Developmental origins of noncommunicable disease: implications for research and public health. Environ Health 2012; 11:42.
21. Barker DJ. The fetal and infant origins of adult disease. Br Med J 1990; 301:1111.
22. Sudo N, Sawamura S, Tanaka K, et al. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997; 159:1739-1745.
23. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science 2012; 336:1268-1273.
24. Kollmann TR, Levy O, Montgomery RR, Goriely S. Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity 2012; 37:771-783.
25. Kolokotroni O, Middleton N, Gavatha M, et al. Asthma and atopy in children born by caesarean section: effect modification by family history of allergies: a population based cross-sectional study. BMC Pediatr 2012; 12:179.
26. Azad MB, Konya T, Maughan H, et al. Infant gut microbiota and the hygiene hypothesis of allergic disease: impact of household pets and siblings on microbiota composition and diversity. Allergy Asthma Clin Immunol 2013; 9:15.
27. Azad MB, Becker AB, Guttman DS, et al. Gut microbiota diversity and atopic disease: does breast-feeding play a role? J Allergy Clin Immunol 2013; 131:247-248.
28. Abrahamsson TR, Jakobsson HE, Andersson AF, et al. Low diversity of the gut microbiota in infants with atopic eczema. J Allergy Clin Immunol 2012; 129:434-440; 40 e1-2.
29. Ismail IH, Oppedisano F, Joseph SJ, et al. Reduced gut microbial diversity in early life is associated with later development of eczema but not atopy in highrisk infants. Pediatr Allergy Immunol 2012; 23:674-681.
30. Doll HM, Armitage DW, Daly RA, et al. Utilizing novel diversity estimators to quantify multiple dimensions of microbial biodiversity across domains. BMC Microbiol 2013; 13:259.
31. Holgerson PL, Vestman NR, Claesson R, et al. Oral microbial profile discriminates breast-fed from formula-fed infants. J Pediatr Gastroenterol Nutr 2013; 56:127-136.
32. Vestman NR, Timby N, Holgerson PL, et al. Characterization and in vitro properties of oral lactobacilli in breastfed infants. BMC Microbiol 2013; 13:193.
33. Cutler CW, Jotwani R. Dendritic cells at the oral mucosal interface. J Dental Res 2006; 85:678-689.
34. Hesselmar B, Sjo berg F, Saalman R, et al. Pacifier cleaning practices and risk of allergy development. Pediatrics 2013; 131:e1829-e1837.
35. Bertelsen RJ, Brantsaeter AL, Magnus MC, et al. Probiotic milk consumption in pregnancy and infancy and subsequent childhood allergic diseases. J Allergy Clin Immunol 2014; 133:165-171.e8.
36. FAO/WHO. Guidelines for the evaluation of probiotics in food. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. World Health Organization, London Ontario, Canada. 2002.
37. West CE, Hernell O, Andersson Y, et al. Probiotic effects on T-cell maturation in infants during weaning. Clin Exp Allergy 2012; 42:540-549.
38. Forsberg A, Abrahamsson TR, Bjo rkste'n B, Jenmalm MC. Pre and postnatal Lactobacillus reuteri supplementation decreases allergen responsiveness in infancy. Clin Exp Allergy 2013; 43:434-442.
39. Chorell E, Karlsson Videhult F, Hernell O, et al. Impact of probiotic feeding during weaning on the serum lipid profile and plasma metabolome in infants. Br J Nutr 2013; 110:116-126.
40. West CE, Prescott SL. Prebiotics and probiotics in prevention of allergic disease. In Basedow D, editor. UptoDate. Waltham MA; 2013.
41. Rautava S, Kainonen E, Salminen S, Isolauri E. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol 2012; 130:1355-1360.
42. Wickens K, Stanley TV, Mitchell EA, et al. Early supplementation with Lactobacillus rhamnosusHN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization? Clin Exp Allergy 2013; 43:1048-1057.
43. Pelucchi C, Chatenoud L, Turati F, et al. Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis. Epidemiology 2012; 23:402-414.
44. Foolad N, Brezinski EA, Chase EP, Armstrong AW. Effect of nutrient supplementation on atopic dermatitis in children: a systematic review of probiotics, prebiotics, formula, and fatty acids. J Am Med Assoc Dermatol 2013; 149:350-355.
45. West CE, Hammarstrom ML, Hernell O. Probiotics in primary prevention of allergic disease: follow-up at 8-9 years of age. Allergy 2013; 68:1015-1020.
46. Abrahamsson TR, Jakobsson T, Bjo rkste'n B, et al. No effect of probiotics on respiratory allergies: a seven-year follow-up of a randomized controlled trial in infancy. Pediatr Allergy Immunol 2013; 24:556-561.
47. Fiocchi A, Burks W, Bahna SL, et al. Clinical use of probiotics in pediatric allergy (CUPPA): a World Allergy Organization position paper. World Allergy Organ J 2012; 5:148-167.
48. Hernell O, West CE. Clinical effects of probiotics: scientific evidence from a paediatric perspective. Br J Nutr 2013; 109 (Suppl 2):S70-S75.
49. Neef A, Sanz Y. Future for probiotic science in functional food and dietary supplement development. Curr Opin Clin Nutr Metab Care 2013; 16:679- 687.
50. Atarashi K, Tanoue T, Oshima K, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013; 500:232-236.
51. Arpaia N, Campbell C, Fan X, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013. [Epub ahead of print]
52. Bertazzoni E, Donelli G, Midtvedt T, et al. Probiotics and clinical effects: is the number what counts? J Chemother 2013; 25:193-212.
53. Harb H, van Tol EA, Heine H, et al. Neonatal supplementation of processed supernatant from Lactobacillus rhamnosus GG improves allergic airway inflammation in mice later in life. Clin Exp Allergy 2013; 43:353-364.
54. Pfefferle PI, Prescott SL, Kopp M. Microbial influence on tolerance and opportunities for intervention with prebiotics/probiotics and bacterial lysates. J Allergy Clin Immunol 2013; 131:1453-1463. [quiz 64].
55. Lau S. Oral application of bacterial lysate in infancy diminishes the prevalence of atopic dermatitis in children at risk for atopy. Benef Microbes 2013; 25: 1-3.
56. Lau S, Gerhold K, Zimmermann K, et al. Oral application of bacterial lysate in infancy decreases the risk of atopic dermatitis in children with 1 atopic parent in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2012; 129:1040-1047.
57. Scott KP, Martin JC, Duncan SH, Flint HJ. Prebiotic stimulation of human colonic butyrate-producing bacteria and bifidobacteria, in vitro. FEMS Microbiol Ecol 2014; 87:30-40.
58. Jeurink PV, van Esch BC, Rijnierse A, et al. Mechanisms underlying immune effects of dietary oligosaccharides. Am J Clin Nutr 2013; 98:572S-577S.
59. Arslanoglu S, Moro GE, Boehm G, et al. Early neutral prebiotic oligosaccharide supplementation reduces the incidence of some allergic manifestations in the first 5 years of life. J Biol Regul Homeost Agents 2012; 26 (3 Suppl):49- 59.
60. Osborn DA, Sinn JK. Prebiotics in infants for prevention of allergy. Cochrane Database Syst Rev 2013; 3:CD006474.
61. Vulevic J, Juric A, Tzortzis G, Gibson GR. A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J Nutr 2013; 143:324- 331.
62. Schijf MA, Kerperien J, Bastiaans J, et al. Alterations in regulatory T cells induced by specific oligosaccharides improve vaccine responsiveness in mice. PLoS One 2013; 8:e75148.